International Clinical Trial: A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Eltrombopag Olamine 25 mg Film-coated Tablets and Reference Product (Revolade) in Healthy Thai Volunteers under Fasting Conditions

Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (TCTR20250910007) titled 'A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Eltrombopag Olamine 25 mg Film-coated Tablets and Reference Product (Revolade) in Healthy Thai Volunteers under Fasting Conditions' on Sept. 10.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: International Bio Service Co., Ltd.

Condition: Bioequivalence study in healthy Thai volunteers Eltrombopag Olamine, Bioequivalence study, Healthy Eltrombopag Olamine, Bioequivalence study, Healthy

Intervention: Each tablet contains 25 mg of eltrombopag.,Each film-coated tablet contains eltrombopag olamine eq...